You are here

skeletal metastases

FDA Grants Priority Review Designation to Denosumab Biologics License Application for the Reduction of Skeletal Related Events in Advanced Cancer Patients

Yahoo/PR NewsWire

Sat, 07/17/10 - 09:52 am

skeletal metastases